Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Internally administered therapeutic agents for cranial nerve diseases comprising mesenchymal cells as an active ingredient

Internally administered therapeutic agents for cranial nerve diseases comprising mesenchymal cells as an active ingredient

US Patent 7968088 · Granted Jun 28, 2011

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating a tumor by administering a claudin-6 (CLDN6) or CLDN9 antibo2025
Antibody-drug conjugates comprising substituted benzo[e]pyrrolo[1,2-a][1,4]diaze2025
Observation device2024
Image forming apparatus2024
Synapse formation agent2023
Antibody-drug conjugates comprising substituted benzo[e]pyrrolo[1,2-α][1,4]diaze2023
Antibody-pyrrolobenzodiazepine derivative conjugate and method of use thereof fo2023
Cell growth method and pharmaceutical preparation for tissue repair and regenera2022
Anti-TROP2 antibody-drug conjugate2021
Bearing component, rotating device using the same, and image forming apparatus2021
Mesenchymal stem cell and the method of use thereof2020
Autoserum-containing bone marrow cell culture system, autoserum-containing bone 2020